Does ENZALUTAMIDE Cause Incorrect product storage? 100 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 100 reports of Incorrect product storage have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.2% of all adverse event reports for ENZALUTAMIDE.
100
Reports of Incorrect product storage with ENZALUTAMIDE
0.2%
of all ENZALUTAMIDE reports
3
Deaths
6
Hospitalizations
How Dangerous Is Incorrect product storage From ENZALUTAMIDE?
Of the 100 reports, 3 (3.0%) resulted in death, 6 (6.0%) required hospitalization.
Is Incorrect product storage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 100 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Incorrect product storage?
ETANERCEPT (2,149)
INSULIN LISPRO (1,114)
ABATACEPT (583)
TERIPARATIDE (573)
ADALIMUMAB (476)
GOLIMUMAB (392)
INSULIN GLARGINE (341)
INSULIN HUMAN (336)
USTEKINUMAB (299)
ERYTHROPOIETIN (268)
Which ENZALUTAMIDE Alternatives Have Lower Incorrect product storage Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE